Table 3.
Details of surgical treatment and sentinel lymph node biopsy
| No. | % | |
|---|---|---|
| Type of surgery performed on primary tumor | ||
| Segmental mastectomy | 41 | 80.4% |
| Segmental mastectomy | 10 | 19.6% |
| Method of lymphatic mapping | ||
| Blue dye only | 8 | 15.7% |
| Radioactive colloid only | 7 | 13.7% |
| Both | 36 | 70.6% |
| Location of radiocolloid injection | ||
| Subareolar | 17 | 33.3% |
| Peritumoral | 34 | 66.7% |
| Operator | ||
| Chief physician | 29 | 56.7% |
| Associate Chief Physician | 16 | 31.4% |
| Other | 6 | 11.8% |
| SLN identified | ||
| Yes | 43 | 84.3% |
| No | 8 | 15.7% |
| Median number of SLNs identified (range) | 2.4 (1–7) | |
SLN, sentinel lymph node.